Maxcyte (MXCT) Assets Average (2021 - 2026)

Maxcyte (MXCT) has 6 years of Assets Average data on file, last reported at $198.5 million in Q1 2026.

• Quarterly Assets Average fell 15.43% year-over-year to $198.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198.5 million (down 15.43% YoY) and the FY2025 annual result came in at $221.0 million, down 12.95% from the prior year.
• Assets Average declined to $198.5 million in Q1 2026 per MXCT's latest filing, from $208.0 million in the prior quarter.
• Across five years, Assets Average topped out at $290.4 million in Q2 2022 and bottomed at $198.5 million in Q1 2026.
• The 5-year median for Assets Average is $263.1 million (2024), against an average of $255.5 million.
• The widest annual swing landed in 2022, when Assets Average soared 55.38%; it then dropped 15.43% in 2026.
• Tracing MXCT's Assets Average over 5 years: stood at $286.5 million in 2022, then decreased by 6.64% to $267.5 million in 2023, then decreased by 8.77% to $244.0 million in 2024, then declined by 14.77% to $208.0 million in 2025, then retreated by 4.57% to $198.5 million in 2026.
• Per Business Quant, the three latest MXCT Assets Average figures stand at $198.5 million (Q1 2026), $208.0 million (Q4 2025), and $216.6 million (Q3 2025).

Peer Comparison